Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Claudia Pastori"'
Autor:
Maddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, Norma Maugeri, Claudia De Lalla, Gabriel Siracusano, Nicola Ivan Lorè, Paola Maria Vittoria Rancoita, Federica Cugnata, Elena Tassi, Stefania Dispinseri, Danilo Abbati, Valeria Beretta, Eliana Ruggiero, Francesco Manfredi, Aurora Merolla, Elisa Cantarelli, Cristina Tresoldi, Claudia Pastori, Roberta Caccia, Francesca Sironi, Ilaria Marzinotto, Fabio Saliu, Silvia Ghezzi, Vito Lampasona, Elisa Vicenzi, Paola Cinque, Angelo Andrea Manfredi, Gabriella Scarlatti, Paolo Dellabona, Lucia Lopalco, Clelia Di Serio, Mauro Malnati, Fabio Ciceri, Patrizia Rovere-Querini, Chiara Bonini
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionSARS-CoV-2 pandemic still poses a significant burden on global health and economy, especially for symptoms persisting beyond the acute disease. COVID-19 manifests with various degrees of severity and the identification of early biomarkers
Externí odkaz:
https://doaj.org/article/54dd8448162f4249ab6637c4ad719bed
Autor:
Maria Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, Claudia Pastori, Claude Capron, Arielle R. Rosenberg, Nigel Temperton, Diego Cantoni, Hanqing Liao, Nicola Ternette, Pierre Moine, Mathieu Godement, Guillaume Geri, Jean-Daniel Chiche, Djillali Annane, Elisabeth Cramer Bordé, Lucia Lopalco, Morgane Bomsel
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The role of the mucosal pulmonary antibody response in coronavirus disease 2019 (COVID-19) outcome remains unclear. Here, we found that in bronchoalveolar lavage (BAL) samples from 48 patients with severe COVID-19-infected with the ancestral Wuhan vi
Externí odkaz:
https://doaj.org/article/da0c0729bf124803ba74929d5054462a
Autor:
Gabriel Siracusano, Annamaria Finardi, Claudia Pastori, Vittorio Martinelli, Roberto Furlan, Lucia Lopalco
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Recent studies showed that immunological tolerance may restrict the development of Env-specific autoreactive broadly neutralizing antibodies. This evidence is consistent with the finding that Env immunization of a systemic lupus erythematosus (SLE) m
Externí odkaz:
https://doaj.org/article/34502d4afc734c31a98121ecd06cfa5a
Autor:
Gabriel Siracusano, Chiara Brombin, Claudia Pastori, Federica Cugnata, Maddalena Noviello, Elena Tassi, Denise Princi, Diego Cantoni, Mauro S. Malnati, Norma Maugeri, Carla Bozzi, Gianni Saretto, Nicola Clementi, Nicasio Mancini, Caterina Uberti-Foppa, Nigel Temperton, Chiara Bonini, Clelia Di Serio, Lucia Lopalco
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
This contribution explores in a new statistical perspective the antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 141 coronavirus disease 2019 (COVID-19) patients exhibiting a broad range of clinical manifestations
Externí odkaz:
https://doaj.org/article/ba2acdc302b1404e96201e96c566a473
Autor:
Diego Cantoni, Gabriel Siracusano, Martin Mayora-Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lucia Lopalco, Nigel Temperton
Publikováno v:
Vaccines, Vol 11, Iss 1, p 58 (2022)
Coronaviruses infections, culminating in the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic beginning in 2019, have highlighted the importance of effective vaccines to induce an antibody response with cross-neutralizing
Externí odkaz:
https://doaj.org/article/7cfe2b0cf9f6434187473cd4740ebf48
Autor:
Martina Ranzenigo, Claudia Pastori, Gabriel Siracusano, Elena Pariani, Caterina Uberti-Foppa, Lucia Lopalco
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is primarily diagnosed through viral RNA positivity in nasopharyngeal swabs, and it is associated with the early detection of specific immunoglobulins to SARS-CoV-2 proteins. We d
Externí odkaz:
https://doaj.org/article/5740d4d14a7c40788ab825ea3350b3f2
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The novel SARS-CoV-2 is a recently emerging virus causing a human pandemic. A great variety of symptoms associated with COVID-19 disease, ranging from mild to severe symptoms, eventually leading to death. Specific SARS-CoV-2 RT-PCR is the standard me
Externí odkaz:
https://doaj.org/article/6a8bb29de21a451c82c1db9fab31fb47
Autor:
Andrea Elizabeth Verna, Valentina Franceschi, Giulia Tebaldi, Francesca Macchi, Valentina Menozzi, Claudia Pastori, Lucia Lopalco, Simone Ottonello, Sandro Cavirani, Gaetano Donofrio
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Bovine herpesvirus 4 (BoHV-4) is a promising vector for the delivery and intracellular expression of recombinant antigens and can thus be considered as a new prototype vaccine formulation system. An interesting, and actively pursued, antigen in the c
Externí odkaz:
https://doaj.org/article/b4070a21624548d288ecd11298d433c3
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The CC chemokine receptor 5 (CCR5) is responsible for immune and inflammatory responses by mediation of chemotactic activity in leukocytes, although it is expressed on different cell types. It has been shown to act as co-receptor for the human and si
Externí odkaz:
https://doaj.org/article/23ff2b29e47d4abaadaecece1af16bc7
Autor:
Assunta Venuti, Claudia Pastori, Gabriel Siracusano, Rosamaria Pennisi, Agostino Riva, Massimo Tommasino, Maria Teresa Sciortino, Lucia Lopalco
Publikováno v:
Viruses, Vol 10, Iss 1, p 9 (2017)
The exposure to CCR5 (CC chemokine receptor 5) specific natural antibodies in vitro produces a Class B β-arrestin2-dependent CCR5 retention with the aid of ERK1, due to the formation of a CCR5 signalosome, which remains stable for at least 48 h. Con
Externí odkaz:
https://doaj.org/article/24c97882372c45d0b8ef734aafe76e57